Report of Foreign Issuer (6-k)
September 05 2019 - 7:39AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF
1934
For the month of September 2019
Commission File Number: 001-39034
BELLUS Health Inc.
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Quebec
H7V 4A7 Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BELLUS Health Inc.
|
|
|
|
|
|
|
|
|
Date: September 5, 2019
|
By:
|
/s/ Francois Desjardins
|
|
|
Name:
|
Francois Desjardins
|
|
|
Title:
|
Vice President, Finance
|
Form 6-K Exhibit Index
Exhibit
Number
|
|
Document Description
|
|
|
|
99.1
|
|
News Release dated September 5, 2019. BELLUS Health Announces Pricing of US$70 Million Public Offering in Canada and the United States.
|